Skip to main content

Featured Content

Methamphetamine overdose deaths soared across the U.S. from 2011-18, with American Indians and Alaska Natives registering the highest death rates overall, according to a study conducted at the National Institute on Drug Abuse.
As part of its Project DAWN initiative, MetroHealth in Cleveland has outfitted an RV it can use to distribute naloxone, serve as a syringe exchange and provide other resources to at-risk individuals in Northeast Ohio.
Toronto-based Awakn Life Sciences and contract research organization PRA Health Sciences have announced plans to study MDMA-assisted psychotherapy as a treatment for patients with alcohol use disorder.
HHS is publishing new guidelines that will expand access to medication-assisted treatment for opioid use disorder by exempting physicians from certain certification requirements necessary for prescribing buprenorphine.
Results of a clinical trial published by NIH on Wednesday showed that a combination of two medications—injectable naltrexone and oral bupropion—were safe and effective in the treatment of adults with moderate or severe methamphetamine use disorder.

Meetings & Publications

Back to Top